Vanguard Group
CHTP

Vanguard Group’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Vanguard Group’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-2,559,190
Closed -$14.1M – 4010
2014
Q1 		$14.1M Sell
2,559,190
-156,051
-6% -$783K ﹤0.01% 2324
2013
Q4 		$12M Buy
2,715,241
+551,357
+25% +$1.86M ﹤0.01% 2379
2013
Q3 		$6.51M Buy
2,163,884
+143,082
+7% +$411K ﹤0.01% 2599
2013
Q2 		$4.65M Buy
+2,020,802
New +$4.09M ﹤0.01% 2707

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Vanguard Group's CHTP Position: Q2 2014 in Review

Vanguard Group sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 2,559,190 shares — an estimated $14.1M sold.

Vanguard Group first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $14.1M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Vanguard Group reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Vanguard Group sold 2,559,190 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $14.1M.
  • Vanguard Group first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Vanguard Group's CHELSEA THERAPEUTICS INT'L LTD position peaked at $14.1M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Vanguard Group's 13F filing for Q2 2014, filed 11 Aug 2014.